Literature DB >> 15222038

Increased hepatic expression of nitric oxide synthase type II in cirrhotic rats.

Hai Wang1, Xiao-Ping Chen, Fa-Zu Qiu.   

Abstract

AIM: To determine the role and effect of nitric oxide synthase type II (NOSII) in cirrhotic rats.
METHODS: Expression of NOSII mRNA was detected by real time RT-PCR. The activity of nitric oxide synthase and serum levels of NO, systemic and portal hemodynamics and degrees of cirrhosis were measured with high sensitive methods. Chinese traditional medicine tetrandrine was used to treat cirrhotic rats and to evaluate the function of NO. Double-blind method was applied during the experiment.
RESULTS: The concentration of NO and the activity of NOS were increased markedly at all stages of cirrhosis, and iNOSmRNA was greatly expressed. Meanwhile the portal-venous-pressure (PVP), and portal-venous-flow (PVF) were significantly increased. NO, NOS and iNOSmRNA were positively correlated to the quantity of hepatic fibrosis. Tetrandrine significantly inhibited NO production and the expression of iNOSmRNA.
CONCLUSION: Increased hepatic expression of NOSII is one of the important causes of hepatic cirrhosis and portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222038      PMCID: PMC4572232          DOI: 10.3748/wjg.v10.i13.1923

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites.

Authors:  M Morales-Ruiz; W Jiménez; D Pérez-Sala; J Ros; A Leivas; S Lamas; F Rivera; V Arroyo
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

2.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

3.  Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats.

Authors:  P A Cahill; E M Redmond; R Hodges; S Zhang; J V Sitzmann
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

4.  Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats.

Authors:  P Y Martin; D L Xu; M Niederberger; A Weigert; P Tsai; J St John; P Gines; R W Schrier
Journal:  Am J Physiol       Date:  1996-03

5.  Rapid, quantitative PCR monitoring of growth of Clostridium botulinum type E in modified-atmosphere-packaged fish.

Authors:  B Kimura; S Kawasaki; H Nakano; T Fujii
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

6.  Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.

Authors:  S Lamas; P A Marsden; G K Li; P Tempst; T Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

7.  Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats.

Authors:  C C Sieber; J C Lopez-Talavera; R J Groszmann
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

8.  Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide.

Authors:  J Clària; W Jiménez; J Ros; M Asbert; A Castro; V Arroyo; F Rivera; J Rodés
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

9.  Lipid peroxidation and extracellular matrix in normal and cirrhotic rat livers following 70% hepatectomy.

Authors:  Fatih Andiran; Kamer Kilinç; Nurten Renda; Ayse Ayhan; F Cahit Tanyel
Journal:  Hepatogastroenterology       Date:  2003 May-Jun

10.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.

Authors:  R S Lin; F Y Lee; S D Lee; Y T Tsai; H C Lin; R H Lu; W C Hsu; C C Huang; S S Wang; K J Lo
Journal:  J Hepatol       Date:  1995-02       Impact factor: 25.083

View more
  1 in total

1.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.